Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2020-006003-42-DK
EUCTR2020-006003-42-DK
Active, not recruiting
Phase 1

ational Cohort Study of Effectiveness and Safety of SARS-CoV-2/Covid-19 vaccines (ENFORCE) - ENFORCE

CHIP - Rigshospitalet - University of Copenhagen0 sites10,000 target enrollmentDecember 21, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsCOMIRNATYCOVID-19 Vaccine Moderna dispersion for injectionCOVID-19 Vaccine AstraZeneca suspension for injectionCOVID-19 Vaccine Janssen suspension for injection

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
CHIP - Rigshospitalet - University of Copenhagen
Enrollment
10000
Status
Active, not recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2020
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHIP - Rigshospitalet - University of Copenhagen

Eligibility Criteria

Inclusion Criteria

  • •1\.Written informed consent obtained before any trial related procedures are performed
  • •2\.Male or female eligible for SARS\-CoV\-2 immunization (as defined by SST in the national vaccination plan)
  • •3\.The subject must be willing and able to comply with trial protocol (re\-visits and biological samples)
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 5000
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 5000

Exclusion Criteria

  • •1\.Male and female under the age of 18
  • •2\.Any subgroup of individuals for which the vaccines are contra\-indicated
  • •3\.Previous SARS\-CoV\-2 vaccination

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients with Muti-gene assayHER2 Positive Elderly Breast Cancer Patients
JPRN-UMIN000051581Public Health Research Foundation266
Completed
Phase 3
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer PatientsHER2 positive primary breast cancer in elderly
JPRN-UMIN000028476RESPECT executive committee300
Recruiting
Phase 4
Effectiveness and safety of COVID-19 vaccines
JPRN-jRCT1051200143Kayeka Hiroshi1,500
Recruiting
Not Applicable
A prospective cohort study of efficacy and safety by methods of the procedure of transcatheter arterial chemoembolization with hepatocellular carcinoma.
JPRN-UMIN000021461Chiba University Hospital225
Completed
Not Applicable
Prospective cohort study for safety and efficacy of low dose nab-paclitaxelBreast cancer
JPRN-UMIN000013275Department of Surgical Oncology Osaka City University Graduate School of Medicine20